Introducing candesartan 32 mg plus hydrochlorothiazide 25 mg in previously untreated patients with severe essential hypertension

PURPOSE: To investigate the efficacy of candesartan 32 mg and hydrochlorothiazide (HCTZ) 25 mg combination in patients with severe essential hypertension. PATIENTS AND METHODS: In this prospective, open-label, single-group study, 106 previously untreated patients with a baseline systolic blood press...

Descripción completa

Detalles Bibliográficos
Autores principales: Baumgart, Peter, Naudts, Ingomar, Kiel, Gerhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045001/
https://www.ncbi.nlm.nih.gov/pubmed/27774009
http://dx.doi.org/10.2147/POR.S18303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045001/
https://www.ncbi.nlm.nih.gov/pubmed/27774009
http://dx.doi.org/10.2147/POR.S18303

Ejemplares similares